4Kuemmerle-Deschner JB,Horneff G.Safety and efficacy of once-weekly application of etanercept in children with juvenile idiopathic arthritis[J].Rheumatol Int,2007,28(2):153-156. 被引量：1
5Horneff G,Ebert A,Fitter S,et al.Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis[J].Rheumatology (Oxford),2009,48(8):916-919. 被引量：1
6Yim DS,Zhou H,Buckwalter M,et al.Population pharma-cokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis[J].J Clin Pharmacol,2005,45(3):246-256. 被引量：1
7Giannini EH,Ruperto N,Ravelli A,et al.Preliminary definition of improvement in juvenile arthritis[J].Arthritis Rheum,1997,40(7):1202-1209. 被引量：1
8Ringold S,Chon Y,Singer NG.Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis:a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis[J].Arthritis Rheum,2009,60(12):3776-3783. 被引量：1
9Wallace CA,Ruperto N,Giannini E.Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis[J].J Rheumatol,2004,31(11):2290-2294. 被引量：1
10Nielsen S,Ruperto N,Gerloni V,et al.Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis[J].Clin Exp Rheumatol,2008,26(4):688-692. 被引量：1
